Trans-ancestry mutational landscape of hepatocellular carcinoma genomesYasushi Totoki, Tatsuhiro Shibata, Kenji Tatsuno et al.|Nature Genetics|2014Cited by 780
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trialMasatoshi Kudo, Yasuaki Arai, Hidetaka Tsumura et al.|Gut|2019Cited by 720
Effect of c-Met inhibitor SU11274 on hepatocellular carcinoma cell growthYoshinori Inagaki, Norihiro Kokudo|BioScience Trends|2011Cited by 42
Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trialOsamu Aramaki, Masashi Fujii, Tadatoshi Takayama et al.|European Journal of Cancer|2021Cited by 24
Dissemination of evidence-based clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists, liver surgeons and primary care physiciansNorihiro Kokudo, Masatoshi Makuuchi, Yo Sasaki et al.|Gut|2007Cited by 19